anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Anticorps

LGALS9 was initially thought to represent a pseudogene of galectin 9; however, this transcript has good exon-intron structure and encodes a predicted protein of the same size as and highly similar to galectin 9. De plus, nous expédions Lectin, Galactoside-Binding, Soluble, 9 Kits (58) et Lectin, Galactoside-Binding, Soluble, 9 Protéines (35) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
LGALS9 16859 O08573
LGALS9 3965 O00182
LGALS9 25476 P97840
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-Lectin, Galactoside-Binding, Soluble, 9 Anticorps sur anticorps-enligne.fr

Showing 10 out of 197 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Fournisseur Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-LGALS9 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: Human Muscle 100 μL Connectez-vous pour afficher 2 to 3 Days
$289.00
Détails
Rat Lapin Inconjugué WB Observed bind size: 36KD 100 μg Connectez-vous pour afficher 4 to 6 Days
$240.00
Détails
Humain Lapin Inconjugué EIA, WB Western blot analysis of Galectin-9 Antibody (N-term) in WiDr cell line lysates (35ug/lane). 0.4 mL Connectez-vous pour afficher 6 to 8 Days
$390.50
Détails
Humain Souris Inconjugué FACS 0.1 mg Connectez-vous pour afficher 6 to 8 Days
$401.50
Détails
Souris Chèvre Inconjugué CyTOF, FACS, ICC, WB Detection of Galectin-9 in Mouse Thymocytes by Flow Cytometry. Galectin-9 in Mouse Splenocytes. Galectin-9 was detected in immersion fixed mouse splenocytes using Goat Anti-Mouse Galectin-9 Antigen Affinity-purified Polyclonal Antibody  at 15 ug/mL for 3 hours at room temperature. Cells were stained using the NorthernLightsル 557-conjugated Anti-Goat IgG Secondary Antibody (red 100 μg Connectez-vous pour afficher 8 to 9 Days
$416.30
Détails
Humain Lapin Inconjugué IF, ELISA, WB Western blot analysis of extracts from HepG2 cells, using LEG9 Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of NIH-3T3 cells, using LEG9 Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Connectez-vous pour afficher 2 to 3 Days
$302.50
Détails
Humain Souris Inconjugué ELISA (Capture), FACS 0.1 mg Connectez-vous pour afficher 6 to 8 Days
$401.50
Détails
Boeuf (Vache) Lapin Inconjugué WB Host: Rabbit Target Name: LGALS9 Sample Tissue: Human HCT15 Whole Cell Antibody Dilution: 1ug/ml 100 μL Connectez-vous pour afficher 2 to 3 Days
$289.00
Détails
Chien Lapin Inconjugué WB 50 μg Connectez-vous pour afficher 7 to 9 Days
$551.83
Détails
Humain Lapin Inconjugué EIA, IF, IHC (p), IP, WB Immunofluorescence analysis of NIH-3T3 cells, using LEG9 Antibody. The picture on the right is treated with the synthesized peptide. Human Thymus: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μL Connectez-vous pour afficher 11 to 13 Days
$455.40
Détails

LGALS9 Anticorps par réactivité, application, clonalité et conjugué

Attributs Application Hôte Clonalité Conjugué
Mouse (Murine) , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Human , , , ,
,
,
, , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,

anti-Lectin, Galactoside-Binding, Soluble, 9 Anticorps mieux référencés

  1. Human Polyclonal LGALS9 Primary Antibody pour ELISA, WB - ABIN561667 : Bellac, Coimbra, Simon, Imboden, Leib: Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis. dans Neurobiology of disease 2007 (PubMed)
    Show all 2 Pubmed References

  2. Mouse (Murine) Polyclonal LGALS9 Primary Antibody pour CyTOF, FACS - ABIN4899254 : Iqbal, Sampaio, Maione, Greco, Niki, Hirashima, Perretti, Cooper: Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect. dans The American journal of pathology 2011 (PubMed)

Plus d’anticorps contre Lectin, Galactoside-Binding, Soluble, 9 partenaires d’interaction

Mouse (Murine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) interaction partners

  1. in a model of experimental autoimmune encephalomyelitis, we show that an agonist of DR3 (Montrer TNFRSF25 Anticorps) suppressed disease, correlating with expansion of CD4 (Montrer CD4 Anticorps)+Foxp3 (Montrer FOXP3 Anticorps)+ Tregs, and this protective effect was lost in Galectin-9-/- mice

  2. Galectin 9 is a novel dectin 1 (Montrer CLEC7A Anticorps) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (Montrer CLEC7A Anticorps)-galectin 9 axis, CD4 (Montrer CD4 Anticorps)(+) and CD8 (Montrer CD8A Anticorps)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.

  3. The Gal-9/Tim-3 (Montrer HAVCR2 Anticorps) signal is important for the regulation of decidua NK cells function, which is beneficial for the maintenance of a normal pregnancy.

  4. These results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of monoclonal IgE to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction.

  5. galectin-9 functions as a novel alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.

  6. Gal-9 has a role in the maintenance of hepatic homeostasis and preventing liver ischemia-reperfusion injury

  7. Gal-9, a natural TIM-3 (Montrer HAVCR2 Anticorps) ligand, was produced primarily by and released from ischemia-reperfusion-stressed hepatocytes, both in vivo and in vitro.

  8. Galectin-9 functions as an astrocyte-microglia communication signal and promotes cytokine production from microglia in a Tim-3 (Montrer HAVCR2 Anticorps) independent manner.

  9. galectin-9, in addition to being an effector molecule for regulatory T cells cells, acts synergistically with TGF-beta (Montrer TGFB1 Anticorps) to enforce iTreg cell differentiation and maintenance.

  10. Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.

Human Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) interaction partners

  1. Significantly elevated Gal-9 levels were found in both minimal-mild (I-II) and moderate-severe (III-IV) stages of endometriosis in comparison with healthy controls.

  2. We investigated tumor-infiltrating CD4 (Montrer CD4 Anticorps) and CD8 (Montrer CD8A Anticorps) T cells and the expression of PD-L1 (Montrer CD274 Anticorps), Galectin-9, and XAGE1 (Montrer XAGE1A Anticorps) in stage I to IIIA lung adenocarcinomas using a tissue microarray to deduce their contribution to overall survival, and our data showed that PD-L1 (Montrer CD274 Anticorps) expression was a positive indicator, whereas Galectin-9 and XAGE1 (Montrer XAGE1A Anticorps) expression was negative.

  3. Tim3 (Montrer HAVCR2 Anticorps)/Gal-9 alleviates the inflammation of TAO patients via suppressing Akt (Montrer AKT1 Anticorps)/NF-kappaB (Montrer NFKB1 Anticorps) signaling pathway.

  4. Low Gal-9 expression is associated with pancreatic and ampullary cancer.

  5. Galectin 9 is a novel dectin 1 (Montrer CLEC7A Anticorps) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (Montrer CLEC7A Anticorps)-galectin 9 axis, CD4 (Montrer CD4 Anticorps)(+) and CD8 (Montrer CD8A Anticorps)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.

  6. X-ray structure of a protease-resistant mutant form of human galectin-9 having two carbohydrate recognition domains with a metal-binding site has been presented.

  7. These findings may indicate that an increase in the Gal-9 level, a novel immune checkpoint molecule, can reflect immune-related adverse effects of various biotherapies.

  8. Our data suggest a role of galectin-9 in regulating HIV transcription and viral production in vivo during therapy

  9. these data suggest that the high Tim-3 (Montrer HAVCR2 Anticorps) expression in monocytes could be utilized by tumor-promoting Gal-9 expression on CD4 (Montrer CD4 Anticorps)(+) T cells

  10. this study shows that in osteosarcoma patients, Tim3 (Montrer HAVCR2 Anticorps) expression did not directly mediate immune suppression, but the interaction between Tim3 (Montrer HAVCR2 Anticorps)+ T cells and monocytes, naive CD4 (Montrer CD4 Anticorps)+ T cells, and Gal9-expressing CD4 (Montrer CD4 Anticorps)+ CD25 (Montrer IL2RA Anticorps)+ Tregs could resulting in progressive suppression of Th1 (Montrer TH1L Anticorps) responses

Cow (Bovine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) interaction partners

  1. The Tim-3 (Montrer HAVCR2 Anticorps)/Gal-9 pathway might link disease progression with T cell exhaustion during bovine leukemia virus infection.

  2. The relative abundance of PIBF (Montrer PIBF1 Anticorps), LGALS1 (Montrer LGALS1 Anticorps), LGALS3 (Montrer LGALS2 Anticorps), LGALS3BP (Montrer LGALS3BP Anticorps), and LGALS9 mRNA would display a differential expression pattern in the endometrium.

Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) profil antigène

Profil protéine

The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency. Multiple alternatively spliced transcript variants have been found for this gene.

Gene names and symbols associated with LGALS9

  • galectin 9 L homeolog (lgals9.L) anticorps
  • galectin 9 (lgals9) anticorps
  • lectin, galactoside-binding, soluble, 9 (galectin 9)-like 3 (lgals9l3) anticorps
  • galectin 9 (LGALS9) anticorps
  • galectin 9 (Lgals9) anticorps
  • lectin, galactose binding, soluble 9 (Lgals9) anticorps
  • AA407335 anticorps
  • AI194909 anticorps
  • AI265545 anticorps
  • ecalectin anticorps
  • gal-9 anticorps
  • galectin-9 anticorps
  • HUAT anticorps
  • Lgals5 anticorps
  • LGALS9 anticorps
  • LGALS9A anticorps
  • LGALS35 anticorps
  • UAT anticorps
  • UATP.I anticorps
  • wu:fd20c09 anticorps
  • zgc:111833 anticorps

Protein level used designations for LGALS9

lectin, galactoside-binding, soluble, 9 , galactoside-binding soluble lectin 9 , galectin 9 , lectin, galactoside-binding, soluble, 9 (galectin 9) , galectin-9 , lectin, galactose binding, soluble 5 , ecalectin , gal-9 , tumor antigen HOM-HD-21 , urate transporter/channel protein , 36 kDa beta-galactoside-binding lectin , Lectin galactose binding soluble 9 (Galectin-9) , Lectin, galactose binding, soluble 9 (Galectin-9) , UAT , urate transporter/channel , urate transporter , urate transporter/channel protein, isoform (UATp,i)

GENE ID SPECIES
733366 Xenopus laevis
100145704 Xenopus (Silurana) tropicalis
327284 Danio rerio
454519 Pan troglodytes
100350347 Oryctolagus cuniculus
100728329 Cavia porcellus
16859 Mus musculus
3965 Homo sapiens
25476 Rattus norvegicus
442861 Canis lupus familiaris
396972 Sus scrofa
510813 Bos taurus
Fournisseurs de qualité sélectionnés pour anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Anticorps
Avez-vous cherché autre chose?